DOI QR코드

DOI QR Code

Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status

  • Won, Jong Chul (Department of Internal Medicine, Cardiovascular and Metabolic Disease Center, Inje University Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Lee, Jae Hyuk (Division of Endocrinology and Metabolism, Department of Internal Medicine, Myongji Hospital) ;
  • Kim, Jae Hyeon (Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, Eun Seok (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Won, Kyu Chang (Department of Internal Medicine, Yeungnam University College of Medicine) ;
  • Kim, Dae Jung (Department of Endocrinology and Metabolism, Ajou University School of Medicine) ;
  • Lee, Moon-Kyu (Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2018.01.29
  • Accepted : 2018.05.02
  • Published : 2018.10.17

Abstract

Background: This report presents the recent prevalence and comorbidities related to diabetes in Korea by analyzing the nationally representative data. Methods: Using data from the Korea National Health and Nutrition Examination Survey for 2013 to 2014, the percentages and the total number of subjects over the age of 30 years with diabetes and prediabetes were estimated and applied to the National Population Census in 2014. Diagnosis of diabetes was based on fasting plasma glucose (${\geq}126mg/dL$), current taking of antidiabetic medication, history of previous diabetes, or glycosylated hemoglobin (HbA1c) ${\geq}6.5%$. Impaired fasting glucose (IFG) was defined by fasting plasma glucose in the range of 100 to 125 mg/dL among those without diabetes. Results: About 4.8 million (13.7%) Korean adults (${\geq}30years$ old) had diabetes, and about 8.3 million (24.8%) Korean adults had IFG. However, 29.3% of the subjects with diabetes are not aware of their condition. Of the subjects with diabetes, 48.6% and 54.7% were obese and hypertensive, respectively, and 31.6% had hypercholesterolemia. Although most subjects with diabetes (89.1%) were under medical treatment, and mostly being treated with oral hypoglycemic agents (80.2%), 10.8% have remained untreated. With respect to overall glycemic control, 43.5% reached the target of HbA1c <7%, whereas 23.3% reached the target when the standard was set to HbA1c <6.5%, according to the Korean Diabetes Association guideline. Conclusion: Diabetes is a major public health threat in Korea, but a significant proportion of adults were not controlling their illness. We need comprehensive approaches to overcome the upcoming diabetes-related disease burden in Korea.

Keywords

References

  1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40-50. https://doi.org/10.1016/j.diabres.2017.03.024
  2. Shin HY, Lee JY, Song J, Lee S, Lee J, Lim B, Kim H, Huh S. Cause-of-death statistics in the Republic of Korea, 2014. J Korean Med Assoc 2016;59:221-32. https://doi.org/10.5124/jkma.2016.59.3.221
  3. Yoon J, Seo H, Oh IH, Yoon SJ. The non-communicable disease burden in Korea: findings from the 2012 Korean Burden of Disease Study. J Korean Med Sci 2016;31 Suppl 2:S158-67. https://doi.org/10.3346/jkms.2016.31.S2.S158
  4. Choi YJ, Lee MS, An SY, Kim TH, Han SJ, Kim HJ, Chung YS, Lee KW, Kim DJ. The relationship between diabetes mellitus and health-related quality of life in Korean adults: the Fourth Korea National Health and Nutrition Examination Survey (2007-2009). Diabetes Metab J 2011;35:587-94. https://doi.org/10.4093/dmj.2011.35.6.587
  5. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
  6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37(Suppl 1):S81-90. https://doi.org/10.2337/dc14-S081
  7. Bassett J; International Diabetes Institute; World Health Organization Regional Office for the Western Pacific; International Association for the Study of Obesity; International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000.
  8. Oh SW, Shin SA, Yun YH, Yoo T, Huh BY. Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obes Res 2004;12:2031-40. https://doi.org/10.1038/oby.2004.254
  9. Korean Diabetes Association. Treatment guideline for diabetes. 5th ed. Seoul: Gold' Planning and Development; 2015.
  10. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2014 update: a report from the American Heart Association. Circulation 2014;129:e28-92. https://doi.org/10.1161/CIRCULATIONAHA.113.003961
  11. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54. https://doi.org/10.7326/0003-4819-145-4-200608150-00004
  12. Ahn JH, Yu JH, Ko SH, Kwon HS, Kim DJ, Kim JH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Han K, Cha BY, Kim NH; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence and determinants of diabetic nephropathy in Korea: Korea National Health and Nutrition Examination Survey. Diabetes Metab J 2014;38:109-19. https://doi.org/10.4093/dmj.2014.38.2.109
  13. Jeon JY, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Jang MJ, Kim Y, Oh K, Kim DJ, Cha BY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c. Diabetes Metab J 2013;37:349-57. https://doi.org/10.4093/dmj.2013.37.5.349
  14. Ko SH, Kwon HS, Kim DJ, Kim JH, Kim NH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Han K, Park YM, Cha BY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Higher prevalence and awareness, but lower control rate of hypertension in patients with diabetes than general population: the Fifth Korean National Health and Nutrition Examination Survey in 2011. Diabetes Metab J 2014;38:51-7. https://doi.org/10.4093/dmj.2014.38.1.51
  15. Roh E, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, Song KH, Won JC, Kim DJ, Choi SH, Lim S, Cha BY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence and management of dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010. Diabetes Metab J 2013;37:433-49. https://doi.org/10.4093/dmj.2013.37.6.433
  16. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J 2011;35:303-8. https://doi.org/10.4093/dmj.2011.35.4.303
  17. Kim CS, Ko SH, Kwon HS, Kim NH, Kim JH, Lim S, Choi SH, Song KH, Won JC, Kim DJ, Cha BY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence, awareness, and management of obesity in Korea: data from the Korea National Health and Nutrition Examination Survey (1998-2011). Diabetes Metab J 2014;38:35-43. https://doi.org/10.4093/dmj.2014.38.1.35
  18. Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, Woodward M, Selvin E. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2017;5:34-42. https://doi.org/10.1016/S2213-8587(16)30321-7
  19. Razavian N, Blecker S, Schmidt AM, Smith-McLallen A, Nigam S, Sontag D. Population-level prediction of type 2 diabetes from claims data and analysis of risk factors. Big Data 2015;3: 277-87. https://doi.org/10.1089/big.2015.0020
  20. Kim S, Moon S, Popkin BM. The nutrition transition in South Korea. Am J Clin Nutr 2000;71:44-53. https://doi.org/10.1093/ajcn/71.1.44
  21. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93. https://doi.org/10.1056/NEJMoa021778
  22. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39. https://doi.org/10.1161/01.CIR.0000133317.49796.0E
  23. Ford ES. Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999-2008*. J Diabetes 2011;3:337-47. https://doi.org/10.1111/j.1753-0407.2011.00148.x
  24. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305. https://doi.org/10.1056/NEJMoa041031
  25. Ko SH, Kim SR, Kim DJ, Oh SJ, Lee HJ, Shim KH, Woo MH, Kim JY, Kim NH, Kim JT, Kim CH, Kim HJ, Jeong IK, Hong EK, Cho JH, Mok JO, Yoon KH; Committee of Clinical Practice Guidelines, Korean Diabetes Association. 2011 Clinical practice guidelines for type 2 diabetes in Korea. Diabetes Metab J 2011;35:431-6. https://doi.org/10.4093/dmj.2011.35.5.431
  26. Noh J, Han KD, Ko SH, Ko KS, Park CY. Trends in the pervasiveness of type 2 diabetes, impaired fasting glucose and co-morbidities during an 8-year-follow-up of nationwide Korean population. Sci Rep 2017;7:46656. https://doi.org/10.1038/srep46656
  27. Kim JA, Yoon S, Kim LY, Kim DS. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci 2017;32:718-28. https://doi.org/10.3346/jkms.2017.32.5.718
  28. Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus of Korean Diabetes Association, Park IeB, Kim J, Kim DJ, Chung CH, Oh JY, Park SW, Lee J, Choi KM, Min KW, Park JH, Son HS, Ahn CW, Kim H, Lee S, Lee IB, Choi I, Baik SH. Diabetes epidemics in Korea: reappraise nationwide survey of diabetes “diabetes in Korea 2007”. Diabetes Metab J 2013;37: 233-9. https://doi.org/10.4093/dmj.2013.37.4.233
  29. Chun H, Kim IH, Min KD. Accuracy of self-reported hypertension, diabetes, and hypercholesterolemia: analysis of a representative sample of Korean older adults. Osong Public Health Res Perspect 2016;7:108-15. https://doi.org/10.1016/j.phrp.2015.12.002
  30. Choi YJ, Kim HC, Kim HM, Park SW, Kim J, Kim DJ. Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998-2005. Diabetes Care 2009;32:2016-20. https://doi.org/10.2337/dc08-2228

Cited by

  1. Trends of Diabetes Epidemic in Korea vol.42, pp.5, 2018, https://doi.org/10.4093/dmj.2018.0194
  2. Fifty Years of Compassionate Care and Harmonious Collaboration of the Korean Diabetes Association: The 50th Anniversary of Korean Diabetes Association vol.42, pp.6, 2018, https://doi.org/10.4093/dmj.2018.0231
  3. A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52 : A protocol for mixed treatment comparisons meta-analysis vol.98, pp.47, 2019, https://doi.org/10.1097/md.0000000000017976
  4. Letter: Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data ( Diabetes Metab J 2019;43:90–6) vol.43, pp.2, 2018, https://doi.org/10.4093/dmj.2019.0056
  5. Diabetes and the Risk of Infection: A National Cohort Study vol.43, pp.6, 2018, https://doi.org/10.4093/dmj.2019.0071
  6. Effects of Blood Pressure and Glucose Levels on Visual Acuity vol.24, pp.2, 2018, https://doi.org/10.14479/jkoos.2019.24.2.181
  7. The Need to Improve the Quality of Diabetes Care in Korea vol.34, pp.31, 2019, https://doi.org/10.3346/jkms.2019.34.e210
  8. Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study vol.10, pp.4, 2018, https://doi.org/10.1007/s13300-019-0658-7
  9. Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86) vol.43, pp.4, 2018, https://doi.org/10.4093/dmj.2019.0130
  10. 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea vol.43, pp.4, 2019, https://doi.org/10.4093/dmj.2019.0137
  11. Poor Control of Blood Glucose, Lifestyle, and Cardiometabolic Parameters in Younger Adult Patients with Type 2 Diabetes Mellitus vol.8, pp.9, 2018, https://doi.org/10.3390/jcm8091405
  12. Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea vol.34, pp.3, 2018, https://doi.org/10.3803/enm.2019.34.3.282
  13. 소청룡탕 복용 후 혈당이 상승한 당뇨병 환자 증례보고 vol.40, pp.5, 2018, https://doi.org/10.22246/jikm.2019.40.5.929
  14. Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors vol.42, pp.11, 2018, https://doi.org/10.2337/dc18-2195
  15. An evaluation of the impact of aggressive hypertension, diabetes and smoking cessation management on CVD outcomes at the population level: a dynamic simulation analysis vol.19, pp.1, 2018, https://doi.org/10.1186/s12889-019-7429-2
  16. Frailty and Disability in Diabetes vol.23, pp.4, 2018, https://doi.org/10.4235/agmr.19.0036
  17. Circulating myokine levels in different stages of glucose intolerance vol.99, pp.8, 2020, https://doi.org/10.1097/md.0000000000019235
  18. Association of Urinary Polycyclic Aromatic Hydrocarbons and Diabetes in Korean Adults: Data from the Korean National Environmental Health Survey Cycle 2 (2012–2014) vol.13, pp.None, 2020, https://doi.org/10.2147/dmso.s276658
  19. γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial vol.44, pp.4, 2020, https://doi.org/10.4093/dmj.2019.0099
  20. Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell vol.44, pp.None, 2018, https://doi.org/10.4093/dmj.2019.0191
  21. Peripheral Arterial Stiffness Increases the Risk of Progression of Renal Disease in Type 2 Diabetic Patients vol.7, pp.None, 2018, https://doi.org/10.3389/fmed.2020.588967
  22. Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study vol.57, pp.2, 2018, https://doi.org/10.1007/s00592-019-01405-7
  23. Non-Exercise Based Estimation of Cardiorespiratory Fitness Mediates Associations between Comorbidities and Health-Related Quality of Life in Older Korean Adults with Diabetes vol.17, pp.4, 2018, https://doi.org/10.3390/ijerph17041164
  24. The Effects of Bariatric Surgery on Type 2 Diabetes in Asian Populations: a Meta-analysis of Randomized Controlled Trials vol.30, pp.3, 2020, https://doi.org/10.1007/s11695-019-04257-w
  25. Glucose-Lowering Effect of Home-Delivered Therapeutic Meals in Patients with Type 2 Diabetes vol.21, pp.1, 2020, https://doi.org/10.4093/jkd.2020.21.1.46
  26. Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin‐naïve people with type 2 diabetes: The EDITION AP randomized controlled trial vol.22, pp.4, 2018, https://doi.org/10.1111/dom.13936
  27. Effects of a Lifestyle-Modification Program on Blood-Glucose Regulation and Health Promotion in Diabetic Patients: A Randomized Controlled Trial vol.10, pp.2, 2018, https://doi.org/10.15280/jlm.2020.10.2.77
  28. Gender differences in adverse event reports associated with antidiabetic drugs vol.10, pp.1, 2018, https://doi.org/10.1038/s41598-020-74000-4
  29. Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease vol.10, pp.1, 2018, https://doi.org/10.1038/s41598-020-74659-9
  30. Present and Future of Digital Health in Diabetes and Metabolic Disease vol.44, pp.6, 2018, https://doi.org/10.4093/dmj.2020.0088
  31. The Associations Between Vitamin D Receptor BsmI and ApaI Polymorphisms and Obesity in Korean Patients with Type 2 Diabetes Mellitus vol.14, pp.None, 2021, https://doi.org/10.2147/dmso.s293032
  32. Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015) vol.45, pp.1, 2021, https://doi.org/10.4093/dmj.2020.0120
  33. Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status vol.45, pp.1, 2018, https://doi.org/10.4093/dmj.2020.0254
  34. East Asian diet‐mimicking diet plan based on the Mediterranean diet and the Dietary Approaches to Stop Hypertension diet in adults with type 2 diabetes: A randomized controlled trial vol.12, pp.3, 2018, https://doi.org/10.1111/jdi.13384
  35. Prediction of Type 2 Diabetes Based on Machine Learning Algorithm vol.18, pp.6, 2018, https://doi.org/10.3390/ijerph18063317
  36. Development of a clinical risk score for incident diabetes: A 10‐year prospective cohort study vol.12, pp.4, 2021, https://doi.org/10.1111/jdi.13382
  37. New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitor vol.36, pp.2, 2021, https://doi.org/10.3803/enm.2021.203
  38. Blood glucose levels and bodyweight change after dapagliflozin administration vol.12, pp.9, 2018, https://doi.org/10.1111/jdi.13516
  39. Occupational Noise Exposure and Incidence of High Fasting Blood Glucose: A 3-Year, Multicenter, Retrospective Study vol.18, pp.17, 2018, https://doi.org/10.3390/ijerph18179388
  40. Young-onset type 2 diabetes in South Korea: a review of the current status and unmet need vol.36, pp.5, 2018, https://doi.org/10.3904/kjim.2021.379
  41. No influence of hepatic steatosis on the 3‐year outcomes of patients with quiescent chronic hepatitis B vol.28, pp.11, 2021, https://doi.org/10.1111/jvh.13594
  42. Blood Pressure and Cardiovascular Disease in Older Patients With Diabetes: Retrospective Cohort Study vol.10, pp.22, 2018, https://doi.org/10.1161/jaha.121.020999
  43. Association between living alone and incident type 2 diabetes among middle-aged individuals in Korea: a nationwide cohort study vol.11, pp.1, 2018, https://doi.org/10.1038/s41598-021-82868-z
  44. Considering serum alanine aminotransferase and gamma-glutamyltransferase levels together strengthen the prediction of impaired fasting glucose risk: a cross-sectional and longitudinal study vol.11, pp.1, 2018, https://doi.org/10.1038/s41598-021-82981-z